New IBRI Study is ‘Essence of Big Data’
The Indiana Biosciences Research Institute in Indianapolis is bringing together several big industry names for a major study on how type 2 diabetes varies in different patients. Inside INdiana Business talks to Chief Executive Officer David Broecker about what he calls a "first-of-its-kind" partnership that involves Eli Lilly and Co., Roche Diagnostics Corp., the Regenstrief Institute and the Indiana University School of Medicine.
Video Player is loading.
This is a modal window.
The media could not be loaded, either because the server or network failed or because the format is not supported.